Vol. 20 No. 3 (2022): Blood Transfusion - 3 2022 (May-June)
Commentary
Original article
-
Two-year neurodevelopmental outcomes of preterm infants who received red blood cell transfusion
-
The impact of timing of intravenous iron supplementation on preoperative haemoglobin in patients scheduled for major surgery
-
Detection of antibodies against SARS-CoV-2 both in plasma pools for fractionation and in commercial intravenous immunoglobulins produced from plasma collected in Italy during the pandemic
-
Preservation of anti-SARS-CoV-2 neutralising antibodies in convalescent plasma after pathogen reduction with methylene blue and visible light
-
Impact of blood source and component manufacturing on neurotrophin content and in vitro cell wound healing
-
Haemostatic profile of riboflavin-treated apheresis platelet concentrates
-
Algorithm development and diagnostic accuracy testing for non-invasive foetal RHD genotyping: an Indian experience
Recommendations
Announcements
Winter Closure
The Editorial Office will be closed from December 31 to January 7, 2026.
Season’s greetings to all our readers, authors, and reviewers.
Read moreSIMTI 2026
46° Convegno Nazionale di Studi di Medicina Trasfusionale - Abstract Book (in Italian)
Read moreSETS 2026
35° Congreso de la Sociedad Española de Transfusión Sanguínea y Terapia Celular - SETS - Abstract Book (in Spanish), is online (https://www.bloodtransfusion.it/bt/issue/view/81).Madrid, 4-6 June 2026.
Read moreEditorial Office Closure Notice
Please note that the BT Editorial Office will be closed until August 26, 2026.
During this period, responses to inquiries and the processing of manuscripts may be delayed. All editorial activities will resume as usual after this date.
Thank you for your understanding.
Best regards,
BT Editorial Office
Read more
Impact Factor 2025
We are pleased to announce that Blood Transfusion has achieved a 2025 Impact Factor of 2.7.
Read more